Article
Immune privilege of endothelial cells differentiated from endothelial progenitor cells.
Cardiovascular research - 1 Oct 2010
Ladhoff Juliane, Fleischer Bernhard, Hara Yoshiaki, Volk Hans-Dieter, Seifert Martina
Abstract excerpt
AIMS: The application of autologous endothelial progenitor cells (EPC) is a promising approach in cardiovascular regeneration, but the availability of cells in appropriate numbers is the limiting factor. Allogeneic EPC would be an alternative, and we therefore analysed the immunogenicity of EPC-derived endothelial cells (EC) to evaluate their potential usefulness. METHODS AND RESULTS: Circulating EPC from rat...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
